GlassScriptPhysician profile
Leonard H Raucher
NPI 1518990696
$9,870.75
in general payments reported to CMS, 2019-2025
48 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $1,630 · 2021: $1,736 · 2022: $992 · 2023: $1,410 · 2024: $1,449 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,292.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,471.51 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,079.42 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $971.87 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $882.44 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $655.43 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $571.91 | 2021-2025 | |
| Antares Pharma, INC. | $570.23 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $558.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $382.43 | 2019-2025 | Capvaxive |
| Exact Sciences Corporation | $279.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $278.76 | 2019-2025 | |
| Astellas Pharma US INC | $214.76 | 2022-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $214.25 | 2019-2023 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $110.84 | 2020-2023 | Airduo Digihaler |
| Bayer Healthcare Pharmaceuticals INC. | $103.04 | 2021-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Raucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.